- Open Access
Mechanisms of lung and diaphragmatic protection by high PEEP in obese COVID-19 ARDS: role of the body mass index
Critical Care volume 26, Article number: 182 (2022)
To the Editor:
Obesity increases the risk of requiring mechanical ventilation (MV) and developing acute respiratory distress syndrome (ARDS) in patients with coronavirus 2019 (COVID-19) .
Spontaneous breathing (SB) may potentially compromise lung and diaphragmatic protection in COVID-19-induced ARDS . In recruitable models, high positive end-expiratory pressure (PEEP) was shown to render SB less injurious . Nonetheless, the effects of high PEEP have been scarcely studied in clinical scenarios. Previous literature suggests that obese subjects might benefit from higher PEEP and these positive effects might be proportional to the obesity grade [4, 5].
We assessed whether the beneficial effects of high PEEP on lung and diaphragmatic protection depend on body mass index (BMI) in intubated obese patients recovering from COVID-19-associated ARDS.
This is an exploratory analysis of a physiological study conducted at Sanatorio Anchorena San Martín, Argentina. Consecutive adults with COVID-19-associated ARDS, BMI > 30 kg/m2, intubation > 48 hs and SB in pressure support for > 2 hs were included.
The pressure support level was titrated by the attending physician. Esophageal pressure (Pes) was measured with an air-filled (1 mL) esophageal balloon (MBMed®-BA-A-008, non-latex) according to manufacturer recommendations after balloon’s correct positioning. Airway pressure, flow, volume and Pes were recorded by a dedicated system (FluxMed, MBMed®).
Our primary endpoints were the changes in muscular pressure (Pmus), pressure–time product per-minute (PTPmin) and dynamic driving transpulmonary pressure (ΔPLdyn) from low-to-high PEEP and its correlation with BMI. Data were collected 10 min after changing PEEP (5–15cmH2O). Respiratory variables averages were computed based on respiratory cycles of the last 30–60 s of each PEEP step considered stable. In 16/21 patients, chest wall elastance (Ecw) was assessed before SB was present. In the remaining, Ecw was measured applying a hyperventilation maneuver by increasing the pressure support until observing positive Pes deflections. All traces were analyzed using Biopac Student Lab PRO®.
Correlations were performed with Spearman's rank test. To assess the differential effects of high PEEP, we analyzed subgroups based on a commonly used BMI cutoff (≥ 35 kg/m2) . A linear mixed-effects regression model for repeated measures was fitted to assess interaction between PEEP (5–15cmH2O) and BMI (≥ or < 35 kg/m2). P values were adjusted by post hoc Tukey’s correction. A two-tailed P ≤ 0.05 was considered statistically significant. Data were analyzed with R4.0.3 software.
We studied 21 patients (age, median [IQR, 25th–75th]: 56 years [IQR, 51–67]; BMI: 34.3 kg/m2 [IQR, 31.6–40.4]). At admission, 85% had moderate ARDS and 3 had mild ARDS. All the patients required neuromuscular blockers and 62% received prone ventilation.
At inclusion, the patients had 5 MV days [IQR, 3–7] and remained ventilated for additional 11 days [IQR, 5–20]. The PaO2/FiO2 was 214 mmHg [IQR, 183–252], pressure support was 8cmH2O [IQR, 5–10], and inspired oxygen was 0.40 [IQR, 0.35–0.50]; the Richmond Agitation–Sedation Scale was − 3 to − 4.
The BMI significantly correlated with changes in Pmus, PTPmin and ΔPLdyn (Fig. 1-A) We found an interaction between BMI and PEEP regarding to changes in Pmus (F(1,19)=6.2;P = 0.022), PTPmin (F(1,19)=7.4, P = 0.013) and ΔPLdyn (F(1,19)=10.4, P = 0.004). Only the subgroup with BMI ≥ 35 reduced the Pmus (mean difference (95%CI): − 3.3cmH2O (− 1.5 to − 6.1)), PTPmin (− 94.5 cmH2O.s/min(− 23.3 to − 165.7)) and ΔPLdyn (− 3.2cmH2O(− 1.6 to − 5.7)) with high PEEP (Fig. 1-B). The results remained significant after excluding an outlier from the severely obese subgroup. In these patients (BMI ≥ 35), the end-expiratory transpulmonary pressure (PLexp) was more negative at low PEEP and became closer to 0cmH2O at high PEEP (Fig. 1-C). The optimization of lung–diaphragmatic protection was explained by reduction of PTP-associated components, improvement in dynamic lung compliance (CLdyn), neuromuscular ventilatory coupling and respiratory drive (Fig. 1-D).
We demonstrate that the obesity grade greatly influences the beneficial effects of PEEP on relevant monitoring variables directly linked to the lung and diaphragmatic protection.
In obese subjects, the increased pleural pressure may reduce end-expiratory lung volume and become PLexp negative, causing atelectasis and airway closure [4, 5]. Alveolar and airways collapse may alter ventilation distribution and cause occult pendelluft, resulting in local/global overdistension . This might impose higher loads on the respiratory muscles, jeopardizing the SB even more .
Our findings indicate that these pathological mechanisms may play a role during SB in obese COVID-19 ARDS patients and can be counteracted by PEEP [4, 5]. Nonetheless, despite fulfilling obesity criteria (BMI > 30 kg/m2), not all patients benefited from high PEEP. Accordingly, the least obese subgroup did not experience work of breathing unloading and deteriorated lung mechanics, neuroventilatory coupling and respiratory drive, suggesting that lung overdistension was probably induced. In this context, we suggest that Pes should be used to titrate PEEP during assisted ventilation to avoid the potential harms associated with unnecessarily high PEEP levels, taking a slightly positive PLexp as a reasonable target .
Our study is mainly limited by the small sample size and the lack of direct measurements of lung–diaphragmatic injury. Additionally, PEEP steps were not random and the time spent during each PEEP level was short.
In summary, considering the complexity of SB in COVID-19-induced ARDS , high PEEP might be considered as a potentially useful tool to provide lung and diaphragmatic protection particularly in selected individuals with BMI ≥ 35 kg/m2, where the obesity-associated mechanical alterations might be specially exacerbated.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
Acute respiratory distress syndrome
Coronavirus disease 2019
Positive end-expiratory pressure
Body mass index
- Pes :
- Pmus :
- PTPmin :
Pressure–time product per minute
- ΔPLdyn :
Peak dynamic driving transpulmonary pressure
- PaO2/FiO2 :
Arterial oxygen pressure to inspired oxygen
Esophageal pressure to neural inspiratory time
- VT/PTPbreath :
Tidal volume-to-pressure–time product per breath
- CLdyn :
Dynamic lung compliance
No statistically significant
Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID-19–related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March–December 2020. MMWR Morb Mortal Wkly Rep. 2021;70:355–61.
Esnault P, Cardinale M, Hraiech S, Goutorbe P, Baumstrack K, Prud’homme E, et al. High respiratory drive and excessive respiratory efforts predict relapse of respiratory failure in critically Ill patients with COVID-19. Am J Respir Crit Care Med. 2020;202(8):1173–8.
Morais CCA, Koyama Y, Yoshida T, Plens GM, Gomes S, Lima CAS, et al. High positive end-expiratory pressure renders spontaneous effort non-injurious. Am J Respir Crit Care Med. 2018;197(10):1285–96.
De Santis Santiago R, Teggia Droghi M, Fumagalli J, Marrazzo F, Florio G, Grassi LG, et al. Lung rescue team investigators. High pleural pressure prevents alveolar overdistension and hemodynamic collapse in ARDS with class III obesity. Am J Respir Crit Care Med. 2020;203(5):575–84.
Teggia Droghi M, De Santis Santiago RR, Pinciroli R, Marrazzo F, Bittner EA, Amato MBP, Kacmarek RM, Berra L. High positive end-expiratory pressure allows extubation of an obese patient. Am J Respir Crit Care Med. 2018;198(4):524–5.
The authors would like to thank Lic. Daniela Ines Gilgado, Lic. Gimena Paola Cardoso and all the staff of the Intensive Care Unit of Sanatorio Anchorena San Martín that made it possible to carry out this investigation.
There was no financial funding.
Ethics approval and consent to participate
The original protocol was approved by the Institutional review board (approval #08-2019) and registered in clinicaltrials.gov (NCT04524091). The informed consent was obtained from the patient's next of kin.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Pérez, J., Dorado, J.H., Navarro, E. et al. Mechanisms of lung and diaphragmatic protection by high PEEP in obese COVID-19 ARDS: role of the body mass index. Crit Care 26, 182 (2022). https://doi.org/10.1186/s13054-022-04051-8